文献速递消化内镜胃肠动力与功能性疾病

胰高血糖素样肽-1受体激动剂对内镜结局的影响:系统综述与Meta分析

Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2024-10-12

该系统综述与Meta分析纳入23项研究共77,152例患者,评估GLP-1受体激动剂(GLP-1RAs)对内镜结局的影响。结果显示,与对照组相比,GLP-1RA组残留胃内容物和手术中止的比值更高,但吸入事件和主观肠道准备质量无显著差异。

要点

  • GLP-1RA组残留胃内容物比值显著高于对照组(OR 15.39,95%CI 4.65-50.99,P<.01)。
  • GLP-1RA组手术中止比值显著高于对照组(OR 13.86,95%CI 4.42-43.43,P<.01)。
  • 两组吸入事件和主观肠道准备质量无显著差异。

核心结论

  • 尽管GLP-1RA组可见残留胃内容物和内镜提前终止达统计学显著,但总体罕见;GLP-1RAs似乎不构成显著风险,因两组吸入事件比值相当。

研究设计与样本

  • 系统综述与Meta分析,检索在线数据库评估GLP-1RAs对比对照组在内镜患者中的研究,纳入23项研究共77,152例患者(GLP-1RA组4449例,对照组72,703例)。

主要发现

  • 患者平均年龄范围47.6至72岁,女性占58.4%。
  • 与对照组相比,GLP-1RA组残留胃内容物比值更高(OR 15.39,95%CI 4.65-50.99,P<.01)。
  • 与对照组相比,GLP-1RA组手术中止比值更高(OR 13.86,95%CI 4.42-43.43,P<.01)。
  • 两组吸入事件无显著差异(OR 21.06,95%CI 0.13-3379.01,P=.24)。
  • 两组主观肠道准备质量无显著差异(OR 0.94,95%CI 0.67-1.31,P=.83)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to cause delayed gastric emptying; however, the effect on clinical outcomes during upper endoscopy and colonoscopy remains unclear. We conducted a meta-analysis to reconcile the data. METHODS: Online databases were searched for studies evaluating GLP-1RAs versus a control group (no GLP-1RAs) in patients undergoing endoscopy. The outcomes of interest were rate of retained gastric contents (RGCs), aborted procedures, aspiration events, and subjective bowel preparation quality. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using a random-effects model. RESULTS: Twenty-three studies with 77,152 patients (4449 in the GLP-1RA arm and 72,703 in the control arm) were included. Mean patient age ranged from 47.6 to 72 years, and 58.4% were women. As compared with the control group, the GLP-1RA group had higher odds of RGCs (OR, 15.39; 95% CI, 4.65-50.99; P < .01) and aborted procedures (OR, 13.86; 95% CI, 4.42-43.43; P < .01). No significant differences were observed between the 2 groups in terms of aspiration events (OR, 21.06; 95% CI, .13-3379.01; P = .24) and subjective bowel preparation quality (OR, .94; 95% CI, .67-1.31; P = .83). CONCLUSIONS: Although statistical significance was reached in terms of visible RGCs and early termination of endoscopies in patients on GLP-1RAs, these events were overall rare. GLP-1RAs do not appear to pose significant risk, as the odds of developing aspiration were comparable in the 2 groups.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Singh S, Rahman SH, Khan N, et al. Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis. Gastrointest Endosc. 2024. PMID: 39401599. doi:10.1016/j.gie.2024.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。